Company: BGLC
Filing Date: 2025-12-02
Form Type: 8-K
Source: 0001477932-25-008724
Chunk: 1

Company: BioNexus Gene Lab Corp
Filing Date: 2025-12-02
Form: 8-K
Item: Item 3.02
Chunk 1
---
)                                                                                             

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BioNexus Gene Lab Corp.

             /s/ Su-Leng Tan Lee      
  By:        Su-Leng Tan Lee          
             Chief Executive Officer  
  Date:      December 2, 2025         

   5